speb/financial-data huggingface dataset:
OXY.TO balance_sheet (quarterly, 2025-03-31) — Capital Stock: 8521000000.00
OXY.TO balance_sheet (quarterly, 2025-03-31) — Cash And Cash Equivalents: 2612000000.00
OXY.TO balance_sheet (quarterly, 2025-03-31) — Cash Cash Equivalents And Short Term Investments: 2612000000.00
OXY.TO cash_flow (quarterly, 2025-03-31) — Cash Dividends Paid: -380000000.00
OXY.TO cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Financing Activities: -928000000.00
OXY.TO cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Investing Activities: -453000000.00
OXY.TO cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Operating Activities: 2032000000.00
OXY.TO cash_flow (quarterly, 2025-03-31) — Cash From Discontinued Financing Activities: -4000000.00
OXY.TO cash_flow (quarterly, 2025-03-31) — Cash From Discontinued Investing Activities: -278000000.00
OXY.TO cash_flow (quarterly, 2025-03-31) — Cash From Discontinued Operating Activities: 116000000.00
OXY.TO cash_flow (quarterly, 2025-03-31) — Change In Inventory: 0.00
OXY.TO cash_flow (quarterly, 2025-03-31) — Change In Other Current Assets: -3000000.00
OXY.TO cash_flow (quarterly, 2025-03-31) — Change In Other Working Capital: 49000000.00
OXY.TO cash_flow (quarterly, 2025-03-31) — Change In Payables And Accrued Expense: -766000000.00
OXY.TO cash_flow (quarterly, 2025-03-31) — Change In Receivables: -19000000.00
OXY.TO cash_flow (quarterly, 2025-03-31) — Change In Working Capital: -739000000.00
OXY.TO cash_flow (quarterly, 2025-03-31) — Changes In Account Receivables: -19000000.00
OXY.TO cash_flow (quarterly, 2025-03-31) — Changes In Cash: 485000000.00
OXY.TO balance_sheet (quarterly, 2025-03-31) — Common Stock: 234000000.00
OXY.TO balance_sheet (quarterly, 2025-03-31) — Common Stock Equity: 26425000000.00
OXY.TO cash_flow (quarterly, 2025-03-31) — Common Stock Issuance: 25000000.00
OXY.TO cash_flow (quarterly, 2025-03-31) — Common Stock Payments: 0.00
OXY.TO income_statement (quarterly, 2025-03-31) — Cost Of Revenue: 3473000000.00
OXY.TO balance_sheet (quarterly, 2025-03-31) — Current Accrued Expenses: 3894000000.00
OXY.TO balance_sheet (quarterly, 2025-03-31) — Current Assets: 9716000000.00
OXY.TO balance_sheet (quarterly, 2025-03-31) — Current Capital Lease Obligation: 542000000.00
OXY.TO balance_sheet (quarterly, 2025-03-31) — Current Debt: 1408000000.00
OXY.TO balance_sheet (quarterly, 2025-03-31) — Current Debt And Capital Lease Obligation: 1950000000.00
OXY.TO balance_sheet (quarterly, 2025-03-31) — Current Liabilities: 9623000000.00
OXY.TO cash_flow (quarterly, 2025-03-31) — Deferred Income Tax: -125000000.00
OXY.TO cash_flow (quarterly, 2025-03-31) — Deferred Tax: -125000000.00
OXY.TO cash_flow (quarterly, 2025-03-31) — Depreciation Amortization Depletion: 1804000000.00
OXY.TO income_statement (quarterly, 2025-03-31) — Diluted Average Shares: 3251864785.00
OXY.TO income_statement (quarterly, 2025-03-31) — Diluted EPS: 0.23
OXY.TO income_statement (quarterly, 2025-03-31) — Diluted NI Availto Com Stockholders: 761000000.00
OXY.TO balance_sheet (quarterly, 2025-03-31) — Duefrom Related Parties Current: 657000000.00
OXY.TO income_statement (quarterly, 2025-03-31) — EBIT: 1487000000.00
OXY.TO income_statement (quarterly, 2025-03-31) — EBITDA: 3291000000.00
OXY.TO income_statement (quarterly, 2025-03-31) — Earnings From Equity Interest: 139000000.00
OXY.TO cash_flow (quarterly, 2025-03-31) — End Cash Position: 2642000000.00
OXY.TO cash_flow (quarterly, 2025-03-31) — Financing Cash Flow: -932000000.00
OXY.TO balance_sheet (quarterly, 2025-03-31) — Finished Goods: 848000000.00
OXY.TO cash_flow (quarterly, 2025-03-31) — Free Cash Flow: 466000000.00
OXY.TO income_statement (quarterly, 2025-03-31) — Gain On Sale Of Ppe: -19000000.00
OXY.TO income_statement (quarterly, 2025-03-31) — Gain On Sale Of Security: 114000000.00
OXY.TO balance_sheet (quarterly, 2025-03-31) — Gains Losses Not Affecting Retained Earnings: 170000000.00
OXY.TO balance_sheet (quarterly, 2025-03-31) — Gross Accounts Receivable: 3633000000.00
OXY.TO balance_sheet (quarterly, 2025-03-31) — Gross PPE: 143269000000.00
OXY.TO income_statement (quarterly, 2025-03-31) — Gross Profit: 2231000000.00
OXY.TO cash_flow (quarterly, 2025-03-31) — Income Tax Paid Supplemental Data: 414000000.00
OXY.TO income_statement (quarterly, 2025-03-31) — Interest Expense: 310000000.00
OXY.TO income_statement (quarterly, 2025-03-31) — Interest Expense Non Operating: 310000000.00
OXY.TO income_statement (quarterly, 2025-03-31) — Interest Income: 53000000.00
OXY.TO income_statement (quarterly, 2025-03-31) — Interest Income Non Operating: 53000000.00
OXY.TO cash_flow (quarterly, 2025-03-31) — Interest Paid Supplemental Data: 486000000.00
OXY.TO balance_sheet (quarterly, 2025-03-31) — Inventories Adjustments Allowances: -93000000.00
OXY.TO balance_sheet (quarterly, 2025-03-31) — Inventory: 2139000000.00
OXY.TO balance_sheet (quarterly, 2025-03-31) — Invested Capital: 51212000000.00
OXY.TO cash_flow (quarterly, 2025-03-31) — Investing Cash Flow: -731000000.00
OXY.TO balance_sheet (quarterly, 2025-03-31) — Investments And Advances: 3121000000.00
OXY.TO cash_flow (quarterly, 2025-03-31) — Issuance Of Capital Stock: 25000000.00
OXY.TO balance_sheet (quarterly, 2025-03-31) — Long Term Capital Lease Obligation: 658000000.00
OXY.TO balance_sheet (quarterly, 2025-03-31) — Long Term Debt: 23379000000.00
OXY.TO balance_sheet (quarterly, 2025-03-31) — Long Term Debt And Capital Lease Obligation: 24037000000.00
OXY.TO cash_flow (quarterly, 2025-03-31) — Long Term Debt Payments: -518000000.00
OXY.TO balance_sheet (quarterly, 2025-03-31) — Long Term Equity Investment: 3121000000.00
OXY.TO balance_sheet (quarterly, 2025-03-31) — Long Term Provisions: 3854000000.00
OXY.TO balance_sheet (quarterly, 2025-03-31) — Minority Interest: 393000000.00
OXY.TO income_statement (quarterly, 2025-03-31) — Minority Interests: -9000000.00
OXY.TO cash_flow (quarterly, 2025-03-31) — Net Business Purchase And Sale: -75000000.00
OXY.TO cash_flow (quarterly, 2025-03-31) — Net Common Stock Issuance: 25000000.00
OXY.TO balance_sheet (quarterly, 2025-03-31) — Net Debt: 22175000000.00
OXY.TO income_statement (quarterly, 2025-03-31) — Net Income: 936000000.00
OXY.TO income_statement (quarterly, 2025-03-31) — Net Income Common Stockholders: 761000000.00
OXY.TO income_statement (quarterly, 2025-03-31) — Net Income Continuous Operations: 830000000.00
OXY.TO income_statement (quarterly, 2025-03-31) — Net Income Discontinuous Operations: 115000000.00
OXY.TO income_statement (quarterly, 2025-03-31) — Net Income From Continuing And Discontinued Operation: 936000000.00
OXY.TO income_statement (quarterly, 2025-03-31) — Net Income From Continuing Operation Net Minority Interest: 821000000.00
OXY.TO cash_flow (quarterly, 2025-03-31) — Net Income From Continuing Operations: 945000000.00
OXY.TO income_statement (quarterly, 2025-03-31) — Net Income Including Noncontrolling Interests: 945000000.00
OXY.TO income_statement (quarterly, 2025-03-31) — Net Interest Income: -257000000.00
OXY.TO cash_flow (quarterly, 2025-03-31) — Net Issuance Payments Of Debt: -518000000.00
OXY.TO cash_flow (quarterly, 2025-03-31) — Net Long Term Debt Issuance: -518000000.00
OXY.TO income_statement (quarterly, 2025-03-31) — Net Non Operating Interest Income Expense: -257000000.00
OXY.TO cash_flow (quarterly, 2025-03-31) — Net Other Financing Charges: -55000000.00
OXY.TO cash_flow (quarterly, 2025-03-31) — Net Other Investing Changes: 1304000000.00
OXY.TO balance_sheet (quarterly, 2025-03-31) — Net PPE: 69152000000.00
OXY.TO balance_sheet (quarterly, 2025-03-31) — Net Tangible Assets: 34712000000.00
OXY.TO balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Liabilities: 5263000000.00
OXY.TO balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Taxes Liabilities: 5263000000.00
OXY.TO income_statement (quarterly, 2025-03-31) — Normalized EBITDA: 3202000000.00
OXY.TO income_statement (quarterly, 2025-03-31) — Normalized Income: 758238742.57
OXY.TO cash_flow (quarterly, 2025-03-31) — Operating Cash Flow: 2148000000.00
OXY.TO cash_flow (quarterly, 2025-03-31) — Operating Gains Losses: 19000000.00
OXY.TO income_statement (quarterly, 2025-03-31) — Operating Income: 1345000000.00
OXY.TO income_statement (quarterly, 2025-03-31) — Operating Revenue: 5813000000.00
OXY.TO balance_sheet (quarterly, 2025-03-31) — Ordinary Shares Number: 942049921.00
OXY.TO balance_sheet (quarterly, 2025-03-31) — Other Current Assets: 699000000.00
OXY.TO balance_sheet (quarterly, 2025-03-31) — Other Current Borrowings: 1408000000.00
OXY.TO balance_sheet (quarterly, 2025-03-31) — Other Equity Adjustments: 170000000.00
OXY.TO income_statement (quarterly, 2025-03-31) — Other Income Expense: 89000000.00
OXY.TO cash_flow (quarterly, 2025-03-31) — Other Non Cash Items: 128000000.00
OXY.TO balance_sheet (quarterly, 2025-03-31) — Other Non Current Assets: 2978000000.00
OXY.TO balance_sheet (quarterly, 2025-03-31) — Other Non Current Liabilities: 7085000000.00
OXY.TO income_statement (quarterly, 2025-03-31) — Other Operating Expenses: 381000000.00
OXY.TO balance_sheet (quarterly, 2025-03-31) — Other Properties: 143269000000.00
OXY.TO income_statement (quarterly, 2025-03-31) — Other Taxes: 264000000.00
OXY.TO income_statement (quarterly, 2025-03-31) — Otherunder Preferred Stock Dividend: 5000000.00
OXY.TO balance_sheet (quarterly, 2025-03-31) — Payables: 3779000000.00
OXY.TO balance_sheet (quarterly, 2025-03-31) — Payables And Accrued Expenses: 7673000000.00
OXY.TO balance_sheet (quarterly, 2025-03-31) — Preferred Stock: 8287000000.00
OXY.TO income_statement (quarterly, 2025-03-31) — Preferred Stock Dividends: 170000000.00
OXY.TO balance_sheet (quarterly, 2025-03-31) — Preferred Stock Equity: 8287000000.00
OXY.TO income_statement (quarterly, 2025-03-31) — Pretax Income: 1177000000.00
OXY.TO balance_sheet (quarterly, 2025-03-31) — Raw Materials: 1384000000.00
OXY.TO balance_sheet (quarterly, 2025-03-31) — Receivables: 4266000000.00
OXY.TO income_statement (quarterly, 2025-03-31) — Reconciled Cost Of Revenue: 3473000000.00
OXY.TO income_statement (quarterly, 2025-03-31) — Reconciled Depreciation: 1804000000.00
OXY.TO cash_flow (quarterly, 2025-03-31) — Repayment Of Debt: -518000000.00
OXY.TO cash_flow (quarterly, 2025-03-31) — Repurchase Of Capital Stock: 0.00
OXY.TO income_statement (quarterly, 2025-03-31) — Restructuring And Mergern Acquisition: 6000000.00
OXY.TO balance_sheet (quarterly, 2025-03-31) — Retained Earnings: 21726000000.00
OXY.TO income_statement (quarterly, 2025-03-31) — Selling General And Administration: 241000000.00
OXY.TO balance_sheet (quarterly, 2025-03-31) — Share Issued: 1170361105.00
OXY.TO income_statement (quarterly, 2025-03-31) — Special Income Charges: -25000000.00
OXY.TO balance_sheet (quarterly, 2025-03-31) — Stockholders Equity: 34712000000.00
OXY.TO balance_sheet (quarterly, 2025-03-31) — Tangible Book Value: 26425000000.00
OXY.TO income_statement (quarterly, 2025-03-31) — Tax Effect Of Unusual Items: 26238742.57
OXY.TO income_statement (quarterly, 2025-03-31) — Tax Provision: 347000000.00
OXY.TO income_statement (quarterly, 2025-03-31) — Tax Rate For Calcs: 0.29
OXY.TO balance_sheet (quarterly, 2025-03-31) — Total Assets: 84967000000.00
OXY.TO balance_sheet (quarterly, 2025-03-31) — Total Capitalization: 58091000000.00
OXY.TO balance_sheet (quarterly, 2025-03-31) — Total Debt: 25987000000.00
OXY.TO balance_sheet (quarterly, 2025-03-31) — Total Equity Gross Minority Interest: 35105000000.00
OXY.TO income_statement (quarterly, 2025-03-31) — Total Expenses: 4359000000.00
OXY.TO balance_sheet (quarterly, 2025-03-31) — Total Liabilities Net Minority Interest: 49862000000.00
OXY.TO balance_sheet (quarterly, 2025-03-31) — Total Non Current Assets: 75251000000.00
OXY.TO balance_sheet (quarterly, 2025-03-31) — Total Non Current Liabilities Net Minority Interest: 40239000000.00
OXY.TO income_statement (quarterly, 2025-03-31) — Total Unusual Items: 89000000.00
OXY.TO income_statement (quarterly, 2025-03-31) — Total Unusual Items Excluding Goodwill: 89000000.00
OXY.TO balance_sheet (quarterly, 2025-03-31) — Treasury Shares Number: 228311184.00
OXY.TO balance_sheet (quarterly, 2025-03-31) — Treasury Stock: 15597000000.00
OXY.TO balance_sheet (quarterly, 2025-03-31) — Working Capital: 93000000.00
OXY.TO income_statement (quarterly, 2025-03-31) — Write Off: 0.00
OXY.TO income_statement (quarterly, 2025-06-30) — +Operating Expense: 1133000000.00
OXY.TO income_statement (quarterly, 2025-06-30) — +Total Revenue: 6414000000.00
OXY.TO balance_sheet (quarterly, 2025-06-30) — Accounts Payable: 3823000000.00
OXY.TO balance_sheet (quarterly, 2025-06-30) — Accounts Receivable: 3469000000.00
OXY.TO balance_sheet (quarterly, 2025-06-30) — Accumulated Depreciation: -75778000000.00
OXY.TO balance_sheet (quarterly, 2025-06-30) — Additional Paid In Capital: 20849000000.00
OXY.TO balance_sheet (quarterly, 2025-06-30) — Allowance For Doubtful Accounts Receivable: -24000000.00
OXY.TO income_statement (quarterly, 2025-06-30) — Basic Average Shares: 3259143351.00
OXY.TO income_statement (quarterly, 2025-06-30) — Basic EPS: 0.08
OXY.TO cash_flow (quarterly, 2025-06-30) — Beginning Cash Position: 2642000000.00
OXY.TO cash_flow (quarterly, 2025-06-30) — Capital Expenditure: -2224000000.00
OXY.TO cash_flow (quarterly, 2025-06-30) — Capital Expenditure Reported: -2224000000.00
OXY.TO balance_sheet (quarterly, 2025-06-30) — Capital Lease Obligations: 1178000000.00
OXY.TO balance_sheet (quarterly, 2025-06-30) — Capital Stock: 8530000000.00
OXY.TO balance_sheet (quarterly, 2025-06-30) — Cash And Cash Equivalents: 2326000000.00
OXY.TO balance_sheet (quarterly, 2025-06-30) — Cash Cash Equivalents And Short Term Investments: 2326000000.00
OXY.TO cash_flow (quarterly, 2025-06-30) — Cash Dividends Paid: -398000000.00
OXY.TO cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Financing Activities: -1247000000.00
OXY.TO cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Investing Activities: -2277000000.00
OXY.TO cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Operating Activities: 3076000000.00
OXY.TO cash_flow (quarterly, 2025-06-30) — Change In Inventory: 243000000.00
OXY.TO cash_flow (quarterly, 2025-06-30) — Change In Other Current Assets: 30000000.00
OXY.TO cash_flow (quarterly, 2025-06-30) — Change In Other Working Capital: -287000000.00
OXY.TO cash_flow (quarterly, 2025-06-30) — Change In Payables And Accrued Expense: 144000000.00
OXY.TO cash_flow (quarterly, 2025-06-30) — Change In Receivables: 74000000.00
OXY.TO cash_flow (quarterly, 2025-06-30) — Change In Working Capital: 204000000.00
OXY.TO cash_flow (quarterly, 2025-06-30) — Changes In Account Receivables: 74000000.00
OXY.TO cash_flow (quarterly, 2025-06-30) — Changes In Cash: -282000000.00
OXY.TO balance_sheet (quarterly, 2025-06-30) — Common Stock: 243000000.00
OXY.TO balance_sheet (quarterly, 2025-06-30) — Common Stock Equity: 27435000000.00
OXY.TO cash_flow (quarterly, 2025-06-30) — Common Stock Issuance: 906000000.00
OXY.TO cash_flow (quarterly, 2025-06-30) — Common Stock Payments: 0.00
OXY.TO income_statement (quarterly, 2025-06-30) — Cost Of Revenue: 4327000000.00
OXY.TO balance_sheet (quarterly, 2025-06-30) — Current Accrued Expenses: 3909000000.00
OXY.TO balance_sheet (quarterly, 2025-06-30) — Current Assets: 8977000000.00
OXY.TO balance_sheet (quarterly, 2025-06-30) — Current Capital Lease Obligation: 547000000.00
OXY.TO balance_sheet (quarterly, 2025-06-30) — Current Debt: 285000000.00
OXY.TO balance_sheet (quarterly, 2025-06-30) — Current Debt And Capital Lease Obligation: 832000000.00
OXY.TO balance_sheet (quarterly, 2025-06-30) — Current Liabilities: 8564000000.00
OXY.TO cash_flow (quarterly, 2025-06-30) — Deferred Income Tax: -21000000.00
OXY.TO cash_flow (quarterly, 2025-06-30) — Deferred Tax: -21000000.00
OXY.TO cash_flow (quarterly, 2025-06-30) — Depreciation Amortization Depletion: 2049000000.00
OXY.TO income_statement (quarterly, 2025-06-30) — Diluted Average Shares: 3342846860.00
OXY.TO income_statement (quarterly, 2025-06-30) — Diluted EPS: 0.08
OXY.TO income_statement (quarterly, 2025-06-30) — Diluted NI Availto Com Stockholders: 261000000.00
OXY.TO balance_sheet (quarterly, 2025-06-30) — Duefrom Related Parties Current: 638000000.00
OXY.TO income_statement (quarterly, 2025-06-30) — EBIT: 1014000000.00
OXY.TO income_statement (quarterly, 2025-06-30) — EBITDA: 3063000000.00
OXY.TO income_statement (quarterly, 2025-06-30) — Earnings From Equity Interest: 24000000.00
OXY.TO cash_flow (quarterly, 2025-06-30) — End Cash Position: 2360000000.00
OXY.TO cash_flow (quarterly, 2025-06-30) — Financing Cash Flow: -1243000000.00
OXY.TO balance_sheet (quarterly, 2025-06-30) — Finished Goods: 546000000.00
OXY.TO cash_flow (quarterly, 2025-06-30) — Free Cash Flow: 736000000.00
OXY.TO income_statement (quarterly, 2025-06-30) — Gain On Sale Of Ppe: -2000000.00
OXY.TO balance_sheet (quarterly, 2025-06-30) — Gains Losses Not Affecting Retained Earnings: 164000000.00
OXY.TO balance_sheet (quarterly, 2025-06-30) — Gross Accounts Receivable: 3493000000.00
OXY.TO balance_sheet (quarterly, 2025-06-30) — Gross PPE: 145241000000.00
OXY.TO income_statement (quarterly, 2025-06-30) — Gross Profit: 2087000000.00
OXY.TO cash_flow (quarterly, 2025-06-30) — Income Tax Paid Supplemental Data: 607000000.00
OXY.TO income_statement (quarterly, 2025-06-30) — Interest Expense: 276000000.00
OXY.TO income_statement (quarterly, 2025-06-30) — Interest Expense Non Operating: 276000000.00
OXY.TO income_statement (quarterly, 2025-06-30) — Interest Income: 44000000.00
OXY.TO income_statement (quarterly, 2025-06-30) — Interest Income Non Operating: 44000000.00
OXY.TO cash_flow (quarterly, 2025-06-30) — Interest Paid Supplemental Data: 168000000.00
OXY.TO balance_sheet (quarterly, 2025-06-30) — Inventories Adjustments Allowances: -93000000.00
OXY.TO balance_sheet (quarterly, 2025-06-30) — Inventory: 1874000000.00
OXY.TO balance_sheet (quarterly, 2025-06-30) — Invested Capital: 50431000000.00
OXY.TO cash_flow (quarterly, 2025-06-30) — Investing Cash Flow: -1999000000.00
OXY.TO balance_sheet (quarterly, 2025-06-30) — Investments And Advances: 2944000000.00
OXY.TO cash_flow (quarterly, 2025-06-30) — Issuance Of Capital Stock: 906000000.00
OXY.TO balance_sheet (quarterly, 2025-06-30) — Long Term Capital Lease Obligation: 631000000.00
OXY.TO balance_sheet (quarterly, 2025-06-30) — Long Term Debt: 22711000000.00
OXY.TO balance_sheet (quarterly, 2025-06-30) — Long Term Debt And Capital Lease Obligation: 23342000000.00
OXY.TO cash_flow (quarterly, 2025-06-30) — Long Term Debt Payments: -1762000000.00
OXY.TO balance_sheet (quarterly, 2025-06-30) — Long Term Equity Investment: 2944000000.00
OXY.TO balance_sheet (quarterly, 2025-06-30) — Long Term Provisions: 3825000000.00
OXY.TO balance_sheet (quarterly, 2025-06-30) — Minority Interest: 454000000.00
OXY.TO income_statement (quarterly, 2025-06-30) — Minority Interests: -10000000.00
OXY.TO cash_flow (quarterly, 2025-06-30) — Net Business Purchase And Sale: -84000000.00
OXY.TO cash_flow (quarterly, 2025-06-30) — Net Common Stock Issuance: 906000000.00
OXY.TO balance_sheet (quarterly, 2025-06-30) — Net Debt: 20670000000.00
OXY.TO income_statement (quarterly, 2025-06-30) — Net Income: 458000000.00
OXY.TO income_statement (quarterly, 2025-06-30) — Net Income Common Stockholders: 261000000.00
OXY.TO income_statement (quarterly, 2025-06-30) — Net Income Continuous Operations: 468000000.00
OXY.TO income_statement (quarterly, 2025-06-30) — Net Income Discontinuous Operations: 0.00
OXY.TO income_statement (quarterly, 2025-06-30) — Net Income From Continuing And Discontinued Operation: 458000000.00
OXY.TO income_statement (quarterly, 2025-06-30) — Net Income From Continuing Operation Net Minority Interest: 458000000.00
OXY.TO cash_flow (quarterly, 2025-06-30) — Net Income From Continuing Operations: 468000000.00
OXY.TO income_statement (quarterly, 2025-06-30) — Net Income Including Noncontrolling Interests: 468000000.00
OXY.TO income_statement (quarterly, 2025-06-30) — Net Interest Income: -232000000.00
OXY.TO cash_flow (quarterly, 2025-06-30) — Net Issuance Payments Of Debt: -1762000000.00
OXY.TO cash_flow (quarterly, 2025-06-30) — Net Long Term Debt Issuance: -1762000000.00
OXY.TO income_statement (quarterly, 2025-06-30) — Net Non Operating Interest Income Expense: -232000000.00
OXY.TO cash_flow (quarterly, 2025-06-30) — Net Other Financing Charges: 7000000.00
OXY.TO cash_flow (quarterly, 2025-06-30) — Net Other Investing Changes: 31000000.00
OXY.TO balance_sheet (quarterly, 2025-06-30) — Net PPE: 69463000000.00
OXY.TO balance_sheet (quarterly, 2025-06-30) — Net Tangible Assets: 35722000000.00
OXY.TO balance_sheet (quarterly, 2025-06-30) — Non Current Deferred Liabilities: 5245000000.00
OXY.TO balance_sheet (quarterly, 2025-06-30) — Non Current Deferred Taxes Liabilities: 5245000000.00
OXY.TO income_statement (quarterly, 2025-06-30) — Normalized EBITDA: 3071000000.00
OXY.TO income_statement (quarterly, 2025-06-30) — Normalized Income: 463040000.00
OXY.TO cash_flow (quarterly, 2025-06-30) — Operating Cash Flow: 2960000000.00
OXY.TO cash_flow (quarterly, 2025-06-30) — Operating Gains Losses: 2000000.00
OXY.TO income_statement (quarterly, 2025-06-30) — Operating Income: 954000000.00
OXY.TO income_statement (quarterly, 2025-06-30) — Operating Revenue: 6318000000.00
OXY.TO balance_sheet (quarterly, 2025-06-30) — Ordinary Shares Number: 984416165.00
OXY.TO balance_sheet (quarterly, 2025-06-30) — Other Current Assets: 670000000.00
OXY.TO balance_sheet (quarterly, 2025-06-30) — Other Current Borrowings: 285000000.00
OXY.TO balance_sheet (quarterly, 2025-06-30) — Other Equity Adjustments: 164000000.00
OXY.TO income_statement (quarterly, 2025-06-30) — Other Income Expense: 16000000.00
OXY.TO cash_flow (quarterly, 2025-06-30) — Other Non Cash Items: 374000000.00
OXY.TO balance_sheet (quarterly, 2025-06-30) — Other Non Current Assets: 2976000000.00
OXY.TO balance_sheet (quarterly, 2025-06-30) — Other Non Current Liabilities: 7208000000.00
OXY.TO income_statement (quarterly, 2025-06-30) — Other Operating Expenses: 580000000.00
OXY.TO balance_sheet (quarterly, 2025-06-30) — Other Properties: 145241000000.00
OXY.TO income_statement (quarterly, 2025-06-30) — Other Taxes: 269000000.00
OXY.TO income_statement (quarterly, 2025-06-30) — Otherunder Preferred Stock Dividend: 27000000.00
OXY.TO balance_sheet (quarterly, 2025-06-30) — Payables: 3823000000.00
OXY.TO balance_sheet (quarterly, 2025-06-30) — Payables And Accrued Expenses: 7732000000.00
OXY.TO balance_sheet (quarterly, 2025-06-30) — Preferred Stock: 8287000000.00
OXY.TO income_statement (quarterly, 2025-06-30) — Preferred Stock Dividends: 170000000.00
OXY.TO balance_sheet (quarterly, 2025-06-30) — Preferred Stock Equity: 8287000000.00
OXY.TO income_statement (quarterly, 2025-06-30) — Pretax Income: 738000000.00
OXY.TO balance_sheet (quarterly, 2025-06-30) — Raw Materials: 1421000000.00
OXY.TO balance_sheet (quarterly, 2025-06-30) — Receivables: 4107000000.00
OXY.TO income_statement (quarterly, 2025-06-30) — Reconciled Cost Of Revenue: 4327000000.00
OXY.TO income_statement (quarterly, 2025-06-30) — Reconciled Depreciation: 2049000000.00
OXY.TO cash_flow (quarterly, 2025-06-30) — Repayment Of Debt: -1762000000.00
OXY.TO cash_flow (quarterly, 2025-06-30) — Repurchase Of Capital Stock: 0.00
OXY.TO income_statement (quarterly, 2025-06-30) — Restructuring And Mergern Acquisition: 6000000.00
OXY.TO balance_sheet (quarterly, 2025-06-30) — Retained Earnings: 21776000000.00
OXY.TO income_statement (quarterly, 2025-06-30) — Selling General And Administration: 284000000.00
OXY.TO balance_sheet (quarterly, 2025-06-30) — Share Issued: 1212727349.00
OXY.TO income_statement (quarterly, 2025-06-30) — Special Income Charges: -8000000.00
OXY.TO balance_sheet (quarterly, 2025-06-30) — Stockholders Equity: 35722000000.00
OXY.TO balance_sheet (quarterly, 2025-06-30) — Tangible Book Value: 27435000000.00
OXY.TO income_statement (quarterly, 2025-06-30) — Tax Effect Of Unusual Items: -2960000.00
OXY.TO income_statement (quarterly, 2025-06-30) — Tax Provision: 270000000.00
OXY.TO income_statement (quarterly, 2025-06-30) — Tax Rate For Calcs: 0.37
OXY.TO balance_sheet (quarterly, 2025-06-30) — Total Assets: 84360000000.00
OXY.TO balance_sheet (quarterly, 2025-06-30) — Total Capitalization: 58433000000.00
OXY.TO balance_sheet (quarterly, 2025-06-30) — Total Debt: 24174000000.00
OXY.TO balance_sheet (quarterly, 2025-06-30) — Total Equity Gross Minority Interest: 36176000000.00
OXY.TO income_statement (quarterly, 2025-06-30) — Total Expenses: 5460000000.00
OXY.TO balance_sheet (quarterly, 2025-06-30) — Total Liabilities Net Minority Interest: 48184000000.00
OXY.TO balance_sheet (quarterly, 2025-06-30) — Total Non Current Assets: 75383000000.00
OXY.TO balance_sheet (quarterly, 2025-06-30) — Total Non Current Liabilities Net Minority Interest: 39620000000.00
OXY.TO income_statement (quarterly, 2025-06-30) — Total Unusual Items: -8000000.00
OXY.TO income_statement (quarterly, 2025-06-30) — Total Unusual Items Excluding Goodwill: -8000000.00
OXY.TO balance_sheet (quarterly, 2025-06-30) — Treasury Shares Number: 228311184.00
OXY.TO balance_sheet (quarterly, 2025-06-30) — Treasury Stock: 15597000000.00
OXY.TO balance_sheet (quarterly, 2025-06-30) — Working Capital: 413000000.00
OXY.TO income_statement (quarterly, 2025-09-30) — +Operating Expense: 987000000.00
OXY.TO income_statement (quarterly, 2025-09-30) — +Total Revenue: 6624000000.00
OXY.TO balance_sheet (quarterly, 2025-09-30) — Accounts Payable: 3532000000.00
OXY.TO balance_sheet (quarterly, 2025-09-30) — Accounts Receivable: 3169000000.00
OXY.TO balance_sheet (quarterly, 2025-09-30) — Accumulated Depreciation: -78333000000.00
OXY.TO balance_sheet (quarterly, 2025-09-30) — Additional Paid In Capital: 20926000000.00
OXY.TO balance_sheet (quarterly, 2025-09-30) — Allowance For Doubtful Accounts Receivable: -24000000.00
OXY.TO income_statement (quarterly, 2025-09-30) — Average Dilution Earnings: 0.00
OXY.TO income_statement (quarterly, 2025-09-30) — Basic Average Shares: 3263444322.00
OXY.TO income_statement (quarterly, 2025-09-30) — Basic EPS: 0.20
OXY.TO cash_flow (quarterly, 2025-09-30) — Beginning Cash Position: 2360000000.00
OXY.TO cash_flow (quarterly, 2025-09-30) — Capital Expenditure: -1768000000.00
OXY.TO cash_flow (quarterly, 2025-09-30) — Capital Expenditure Reported: -1768000000.00
OXY.TO balance_sheet (quarterly, 2025-09-30) — Capital Lease Obligations: 1199000000.00
OXY.TO balance_sheet (quarterly, 2025-09-30) — Capital Stock: 8530000000.00
OXY.TO balance_sheet (quarterly, 2025-09-30) — Cash And Cash Equivalents: 2159000000.00
OXY.TO balance_sheet (quarterly, 2025-09-30) — Cash Cash Equivalents And Short Term Investments: 2159000000.00
OXY.TO cash_flow (quarterly, 2025-09-30) — Cash Dividends Paid: -408000000.00
OXY.TO cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Financing Activities: -1695000000.00
OXY.TO cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Investing Activities: -1259000000.00
OXY.TO cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Operating Activities: 2790000000.00
OXY.TO cash_flow (quarterly, 2025-09-30) — Change In Inventory: -227000000.00
OXY.TO cash_flow (quarterly, 2025-09-30) — Change In Other Current Assets: -103000000.00
OXY.TO cash_flow (quarterly, 2025-09-30) — Change In Other Working Capital: 69000000.00
OXY.TO cash_flow (quarterly, 2025-09-30) — Change In Payables And Accrued Expense: -445000000.00
OXY.TO cash_flow (quarterly, 2025-09-30) — Change In Receivables: 297000000.00
OXY.TO cash_flow (quarterly, 2025-09-30) — Change In Working Capital: -409000000.00
OXY.TO cash_flow (quarterly, 2025-09-30) — Changes In Cash: -164000000.00
OXY.TO balance_sheet (quarterly, 2025-09-30) — Common Stock: 243000000.00
OXY.TO balance_sheet (quarterly, 2025-09-30) — Common Stock Equity: 27974000000.00
OXY.TO cash_flow (quarterly, 2025-09-30) — Common Stock Issuance: 17000000.00
OXY.TO cash_flow (quarterly, 2025-09-30) — Common Stock Payments: 0.00
OXY.TO income_statement (quarterly, 2025-09-30) — Cost Of Revenue: 4463000000.00
OXY.TO balance_sheet (quarterly, 2025-09-30) — Current Accrued Expenses: 3859000000.00
OXY.TO balance_sheet (quarterly, 2025-09-30) — Current Assets: 8812000000.00
OXY.TO balance_sheet (quarterly, 2025-09-30) — Current Capital Lease Obligation: 567000000.00
OXY.TO balance_sheet (quarterly, 2025-09-30) — Current Debt: 1463000000.00
OXY.TO balance_sheet (quarterly, 2025-09-30) — Current Debt And Capital Lease Obligation: 2030000000.00
OXY.TO balance_sheet (quarterly, 2025-09-30) — Current Liabilities: 9421000000.00
OXY.TO cash_flow (quarterly, 2025-09-30) — Deferred Income Tax: 147000000.00
OXY.TO cash_flow (quarterly, 2025-09-30) — Deferred Tax: 147000000.00
OXY.TO cash_flow (quarterly, 2025-09-30) — Depreciation Amortization Depletion: 2061000000.00
OXY.TO income_statement (quarterly, 2025-09-30) — Diluted Average Shares: 3318695255.00
OXY.TO income_statement (quarterly, 2025-09-30) — Diluted EPS: 0.20
OXY.TO income_statement (quarterly, 2025-09-30) — Diluted NI Availto Com Stockholders: 657000000.00
OXY.TO balance_sheet (quarterly, 2025-09-30) — Duefrom Related Parties Current: 667000000.00
OXY.TO income_statement (quarterly, 2025-09-30) — EBIT: 1436000000.00
OXY.TO income_statement (quarterly, 2025-09-30) — EBITDA: 3497000000.00
OXY.TO income_statement (quarterly, 2025-09-30) — Earnings From Equity Interest: 170000000.00
OXY.TO cash_flow (quarterly, 2025-09-30) — End Cash Position: 2196000000.00
OXY.TO cash_flow (quarterly, 2025-09-30) — Financing Cash Flow: -1695000000.00
OXY.TO balance_sheet (quarterly, 2025-09-30) — Finished Goods: 769000000.00
OXY.TO cash_flow (quarterly, 2025-09-30) — Free Cash Flow: 1022000000.00
OXY.TO income_statement (quarterly, 2025-09-30) — Gain On Sale Of Ppe: 34000000.00
OXY.TO balance_sheet (quarterly, 2025-09-30) — Gains Losses Not Affecting Retained Earnings: 204000000.00
OXY.TO balance_sheet (quarterly, 2025-09-30) — Gross Accounts Receivable: 3193000000.00
OXY.TO balance_sheet (quarterly, 2025-09-30) — Gross PPE: 146940000000.00
OXY.TO income_statement (quarterly, 2025-09-30) — Gross Profit: 2161000000.00
OXY.TO cash_flow (quarterly, 2025-09-30) — Income Tax Paid Supplemental Data: 163000000.00
OXY.TO income_statement (quarterly, 2025-09-30) — Interest Expense: 270000000.00
OXY.TO income_statement (quarterly, 2025-09-30) — Interest Expense Non Operating: 270000000.00
OXY.TO income_statement (quarterly, 2025-09-30) — Interest Income: 59000000.00
OXY.TO income_statement (quarterly, 2025-09-30) — Interest Income Non Operating: 59000000.00
OXY.TO cash_flow (quarterly, 2025-09-30) — Interest Paid Supplemental Data: 409000000.00
OXY.TO balance_sheet (quarterly, 2025-09-30) — Inventories Adjustments Allowances: -93000000.00
OXY.TO balance_sheet (quarterly, 2025-09-30) — Inventory: 2117000000.00
OXY.TO balance_sheet (quarterly, 2025-09-30) — Invested Capital: 49651000000.00
OXY.TO cash_flow (quarterly, 2025-09-30) — Investing Cash Flow: -1259000000.00
OXY.TO balance_sheet (quarterly, 2025-09-30) — Investments And Advances: 2989000000.00
OXY.TO cash_flow (quarterly, 2025-09-30) — Issuance Of Capital Stock: 17000000.00
OXY.TO balance_sheet (quarterly, 2025-09-30) — Long Term Capital Lease Obligation: 632000000.00
OXY.TO balance_sheet (quarterly, 2025-09-30) — Long Term Debt: 20214000000.00
OXY.TO balance_sheet (quarterly, 2025-09-30) — Long Term Debt And Capital Lease Obligation: 20846000000.00
OXY.TO cash_flow (quarterly, 2025-09-30) — Long Term Debt Payments: -1304000000.00
OXY.TO balance_sheet (quarterly, 2025-09-30) — Long Term Equity Investment: 2989000000.00
OXY.TO balance_sheet (quarterly, 2025-09-30) — Long Term Provisions: 3856000000.00
OXY.TO balance_sheet (quarterly, 2025-09-30) — Minority Interest: 505000000.00
OXY.TO income_statement (quarterly, 2025-09-30) — Minority Interests: -12000000.00
OXY.TO cash_flow (quarterly, 2025-09-30) — Net Business Purchase And Sale: -68000000.00
OXY.TO cash_flow (quarterly, 2025-09-30) — Net Common Stock Issuance: 17000000.00
OXY.TO balance_sheet (quarterly, 2025-09-30) — Net Debt: 19518000000.00
OXY.TO income_statement (quarterly, 2025-09-30) — Net Income: 830000000.00
OXY.TO income_statement (quarterly, 2025-09-30) — Net Income Common Stockholders: 657000000.00
OXY.TO income_statement (quarterly, 2025-09-30) — Net Income Continuous Operations: 842000000.00
OXY.TO income_statement (quarterly, 2025-09-30) — Net Income Discontinuous Operations: 0.00
OXY.TO income_statement (quarterly, 2025-09-30) — Net Income From Continuing And Discontinued Operation: 830000000.00
OXY.TO income_statement (quarterly, 2025-09-30) — Net Income From Continuing Operation Net Minority Interest: 830000000.00
OXY.TO cash_flow (quarterly, 2025-09-30) — Net Income From Continuing Operations: 842000000.00
OXY.TO income_statement (quarterly, 2025-09-30) — Net Income Including Noncontrolling Interests: 842000000.00
OXY.TO income_statement (quarterly, 2025-09-30) — Net Interest Income: -211000000.00
OXY.TO cash_flow (quarterly, 2025-09-30) — Net Issuance Payments Of Debt: -1304000000.00
OXY.TO cash_flow (quarterly, 2025-09-30) — Net Long Term Debt Issuance: -1304000000.00
OXY.TO income_statement (quarterly, 2025-09-30) — Net Non Operating Interest Income Expense: -211000000.00
OXY.TO cash_flow (quarterly, 2025-09-30) — Net Other Financing Charges: 0.00
OXY.TO cash_flow (quarterly, 2025-09-30) — Net Other Investing Changes: 577000000.00
OXY.TO balance_sheet (quarterly, 2025-09-30) — Net PPE: 68607000000.00
OXY.TO balance_sheet (quarterly, 2025-09-30) — Net Tangible Assets: 36261000000.00
OXY.TO balance_sheet (quarterly, 2025-09-30) — Non Current Deferred Liabilities: 5402000000.00
OXY.TO balance_sheet (quarterly, 2025-09-30) — Non Current Deferred Taxes Liabilities: 5402000000.00
OXY.TO income_statement (quarterly, 2025-09-30) — Normalized EBITDA: 3464000000.00
OXY.TO income_statement (quarterly, 2025-09-30) — Normalized Income: 806240000.00
OXY.TO cash_flow (quarterly, 2025-09-30) — Operating Cash Flow: 2790000000.00
OXY.TO cash_flow (quarterly, 2025-09-30) — Operating Gains Losses: -34000000.00
OXY.TO income_statement (quarterly, 2025-09-30) — Operating Income: 1174000000.00
OXY.TO income_statement (quarterly, 2025-09-30) — Operating Revenue: 6682000000.00
OXY.TO balance_sheet (quarterly, 2025-09-30) — Ordinary Shares Number: 985175029.00
OXY.TO balance_sheet (quarterly, 2025-09-30) — Other Current Assets: 700000000.00
OXY.TO balance_sheet (quarterly, 2025-09-30) — Other Current Borrowings: 1463000000.00
OXY.TO balance_sheet (quarterly, 2025-09-30) — Other Equity Adjustments: 204000000.00
OXY.TO income_statement (quarterly, 2025-09-30) — Other Income Expense: 203000000.00
OXY.TO cash_flow (quarterly, 2025-09-30) — Other Non Cash Items: 183000000.00
OXY.TO balance_sheet (quarterly, 2025-09-30) — Other Non Current Assets: 3064000000.00
OXY.TO balance_sheet (quarterly, 2025-09-30) — Other Non Current Liabilities: 7181000000.00
OXY.TO income_statement (quarterly, 2025-09-30) — Other Operating Expenses: 462000000.00
OXY.TO balance_sheet (quarterly, 2025-09-30) — Other Properties: 146940000000.00
OXY.TO income_statement (quarterly, 2025-09-30) — Other Taxes: 248000000.00
OXY.TO income_statement (quarterly, 2025-09-30) — Otherunder Preferred Stock Dividend: 4000000.00
OXY.TO balance_sheet (quarterly, 2025-09-30) — Payables: 3532000000.00
OXY.TO balance_sheet (quarterly, 2025-09-30) — Payables And Accrued Expenses: 7391000000.00
OXY.TO balance_sheet (quarterly, 2025-09-30) — Preferred Stock: 8287000000.00
OXY.TO income_statement (quarterly, 2025-09-30) — Preferred Stock Dividends: 169000000.00
OXY.TO balance_sheet (quarterly, 2025-09-30) — Preferred Stock Equity: 8287000000.00
OXY.TO income_statement (quarterly, 2025-09-30) — Pretax Income: 1166000000.00
OXY.TO cash_flow (quarterly, 2025-09-30) — Purchase Of Business: -123000000.00
OXY.TO balance_sheet (quarterly, 2025-09-30) — Raw Materials: 1441000000.00
OXY.TO balance_sheet (quarterly, 2025-09-30) — Receivables: 3836000000.00
OXY.TO income_statement (quarterly, 2025-09-30) — Reconciled Cost Of Revenue: 4463000000.00
OXY.TO income_statement (quarterly, 2025-09-30) — Reconciled Depreciation: 2061000000.00
OXY.TO cash_flow (quarterly, 2025-09-30) — Repayment Of Debt: -1304000000.00
OXY.TO cash_flow (quarterly, 2025-09-30) — Repurchase Of Capital Stock: 0.00
OXY.TO income_statement (quarterly, 2025-09-30) — Restructuring And Mergern Acquisition: 1000000.00
OXY.TO balance_sheet (quarterly, 2025-09-30) — Retained Earnings: 22198000000.00
OXY.TO income_statement (quarterly, 2025-09-30) — Selling General And Administration: 277000000.00
OXY.TO balance_sheet (quarterly, 2025-09-30) — Share Issued: 1213486213.00
OXY.TO income_statement (quarterly, 2025-09-30) — Special Income Charges: 33000000.00
OXY.TO balance_sheet (quarterly, 2025-09-30) — Stockholders Equity: 36261000000.00
OXY.TO balance_sheet (quarterly, 2025-09-30) — Tangible Book Value: 27974000000.00
OXY.TO income_statement (quarterly, 2025-09-30) — Tax Effect Of Unusual Items: 9240000.00
OXY.TO income_statement (quarterly, 2025-09-30) — Tax Provision: 324000000.00
OXY.TO income_statement (quarterly, 2025-09-30) — Tax Rate For Calcs: 0.28
OXY.TO balance_sheet (quarterly, 2025-09-30) — Total Assets: 83472000000.00
OXY.TO balance_sheet (quarterly, 2025-09-30) — Total Capitalization: 56475000000.00
OXY.TO balance_sheet (quarterly, 2025-09-30) — Total Debt: 22876000000.00
OXY.TO balance_sheet (quarterly, 2025-09-30) — Total Equity Gross Minority Interest: 36766000000.00
OXY.TO income_statement (quarterly, 2025-09-30) — Total Expenses: 5450000000.00
OXY.TO balance_sheet (quarterly, 2025-09-30) — Total Liabilities Net Minority Interest: 46706000000.00
OXY.TO balance_sheet (quarterly, 2025-09-30) — Total Non Current Assets: 74660000000.00
OXY.TO balance_sheet (quarterly, 2025-09-30) — Total Non Current Liabilities Net Minority Interest: 37285000000.00
OXY.TO income_statement (quarterly, 2025-09-30) — Total Unusual Items: 33000000.00
OXY.TO income_statement (quarterly, 2025-09-30) — Total Unusual Items Excluding Goodwill: 33000000.00
OXY.TO balance_sheet (quarterly, 2025-09-30) — Treasury Shares Number: 228311184.00
OXY.TO balance_sheet (quarterly, 2025-09-30) — Treasury Stock: 15597000000.00
OXY.TO balance_sheet (quarterly, 2025-09-30) — Working Capital: -609000000.00
OXY.TO income_statement (quarterly, 2025-09-30) — Write Off: 0.00
OXY.TO income_statement (annual, 2025-12-31) — +Operating Expense: 3821000000.00
OXY.TO income_statement (quarterly, 2025-12-31) — +Operating Expense: 723000000.00
OXY.TO income_statement (annual, 2025-12-31) — +Total Revenue: 21593000000.00
OXY.TO income_statement (quarterly, 2025-12-31) — +Total Revenue: 1752000000.00
OXY.TO balance_sheet (annual, 2025-12-31) — Accounts Payable: 3285000000.00
OXY.TO balance_sheet (quarterly, 2025-12-31) — Accounts Payable: 3285000000.00
OXY.TO balance_sheet (annual, 2025-12-31) — Accounts Receivable: 2575000000.00
OXY.TO balance_sheet (quarterly, 2025-12-31) — Accounts Receivable: 2575000000.00
OXY.TO balance_sheet (annual, 2025-12-31) — Accumulated Depreciation: -74110000000.00
OXY.TO balance_sheet (quarterly, 2025-12-31) — Accumulated Depreciation: -74110000000.00
OXY.TO balance_sheet (annual, 2025-12-31) — Additional Paid In Capital: 21008000000.00
OXY.TO balance_sheet (quarterly, 2025-12-31) — Additional Paid In Capital: 21008000000.00
OXY.TO cash_flow (annual, 2025-12-31) — Asset Impairment Charge: 21000000.00
OXY.TO cash_flow (quarterly, 2025-12-31) — Asset Impairment Charge: 21000000.00
OXY.TO balance_sheet (annual, 2025-12-31) — Assets Held For Sale Current: 1176000000.00
OXY.TO balance_sheet (quarterly, 2025-12-31) — Assets Held For Sale Current: 1176000000.00
OXY.TO income_statement (annual, 2025-12-31) — Basic Average Shares: 3227382336.00
OXY.TO income_statement (quarterly, 2025-12-31) — Basic Average Shares: 3268737825.00
OXY.TO income_statement (annual, 2025-12-31) — Basic EPS: 0.50
OXY.TO income_statement (quarterly, 2025-12-31) — Basic EPS: -0.02
OXY.TO cash_flow (annual, 2025-12-31) — Beginning Cash Position: 2157000000.00
OXY.TO cash_flow (quarterly, 2025-12-31) — Beginning Cash Position: 2196000000.00
OXY.TO cash_flow (annual, 2025-12-31) — Capital Expenditure: -6427000000.00
OXY.TO cash_flow (quarterly, 2025-12-31) — Capital Expenditure: -753000000.00
OXY.TO cash_flow (annual, 2025-12-31) — Capital Expenditure Reported: -6427000000.00
OXY.TO cash_flow (quarterly, 2025-12-31) — Capital Expenditure Reported: -753000000.00
OXY.TO balance_sheet (annual, 2025-12-31) — Capital Lease Obligations: 1954000000.00
OXY.TO balance_sheet (quarterly, 2025-12-31) — Capital Lease Obligations: 1954000000.00
OXY.TO balance_sheet (annual, 2025-12-31) — Capital Stock: 8530000000.00
OXY.TO balance_sheet (quarterly, 2025-12-31) — Capital Stock: 8530000000.00
OXY.TO balance_sheet (annual, 2025-12-31) — Cash And Cash Equivalents: 1968000000.00
OXY.TO balance_sheet (quarterly, 2025-12-31) — Cash And Cash Equivalents: 1968000000.00
OXY.TO balance_sheet (annual, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 1968000000.00
OXY.TO balance_sheet (quarterly, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 1968000000.00
OXY.TO cash_flow (annual, 2025-12-31) — Cash Dividends Paid: -1594000000.00
OXY.TO cash_flow (quarterly, 2025-12-31) — Cash Dividends Paid: -408000000.00
OXY.TO cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Financing Activities: -4835000000.00
OXY.TO cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Financing Activities: -965000000.00
OXY.TO cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Investing Activities: -4683000000.00
OXY.TO cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Investing Activities: -694000000.00
OXY.TO cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Operating Activities: 9606000000.00
OXY.TO cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Operating Activities: 1708000000.00
OXY.TO cash_flow (annual, 2025-12-31) — Cash From Discontinued Financing Activities: -9000000.00
OXY.TO cash_flow (annual, 2025-12-31) — Cash From Discontinued Investing Activities: -1116000000.00
OXY.TO cash_flow (annual, 2025-12-31) — Cash From Discontinued Operating Activities: 926000000.00
OXY.TO cash_flow (quarterly, 2025-12-31) — Cash From Discontinued Operating Activities: 926000000.00
OXY.TO cash_flow (annual, 2025-12-31) — Change In Inventory: 12000000.00
OXY.TO cash_flow (quarterly, 2025-12-31) — Change In Inventory: -4000000.00
OXY.TO cash_flow (annual, 2025-12-31) — Change In Other Working Capital: -305000000.00
OXY.TO cash_flow (quarterly, 2025-12-31) — Change In Other Working Capital: -136000000.00
OXY.TO cash_flow (annual, 2025-12-31) — Change In Payables And Accrued Expense: -964000000.00
OXY.TO cash_flow (quarterly, 2025-12-31) — Change In Payables And Accrued Expense: 103000000.00
OXY.TO cash_flow (annual, 2025-12-31) — Change In Receivables: 190000000.00
OXY.TO cash_flow (quarterly, 2025-12-31) — Change In Receivables: -162000000.00
OXY.TO cash_flow (annual, 2025-12-31) — Change In Working Capital: -1067000000.00
OXY.TO cash_flow (quarterly, 2025-12-31) — Change In Working Capital: -123000000.00
OXY.TO cash_flow (annual, 2025-12-31) — Changes In Account Receivables: 252000000.00
OXY.TO cash_flow (annual, 2025-12-31) — Changes In Cash: -111000000.00
OXY.TO cash_flow (quarterly, 2025-12-31) — Changes In Cash: -150000000.00
OXY.TO balance_sheet (annual, 2025-12-31) — Common Stock: 243000000.00
OXY.TO balance_sheet (quarterly, 2025-12-31) — Common Stock: 243000000.00
OXY.TO balance_sheet (annual, 2025-12-31) — Common Stock Equity: 27747000000.00
OXY.TO balance_sheet (quarterly, 2025-12-31) — Common Stock Equity: 27747000000.00
OXY.TO cash_flow (annual, 2025-12-31) — Common Stock Issuance: 966000000.00
OXY.TO cash_flow (quarterly, 2025-12-31) — Common Stock Issuance: 18000000.00
OXY.TO cash_flow (annual, 2025-12-31) — Common Stock Payments: 0.00
OXY.TO cash_flow (quarterly, 2025-12-31) — Common Stock Payments: 0.00
OXY.TO income_statement (annual, 2025-12-31) — Cost Of Revenue: 14050000000.00
OXY.TO income_statement (quarterly, 2025-12-31) — Cost Of Revenue: 912000000.00
OXY.TO balance_sheet (annual, 2025-12-31) — Current Accrued Expenses: 1006000000.00
OXY.TO balance_sheet (quarterly, 2025-12-31) — Current Accrued Expenses: 1006000000.00
OXY.TO balance_sheet (annual, 2025-12-31) — Current Assets: 8827000000.00
OXY.TO balance_sheet (quarterly, 2025-12-31) — Current Assets: 8827000000.00
OXY.TO balance_sheet (annual, 2025-12-31) — Current Capital Lease Obligation: 548000000.00
OXY.TO balance_sheet (quarterly, 2025-12-31) — Current Capital Lease Obligation: 548000000.00
OXY.TO balance_sheet (annual, 2025-12-31) — Current Debt: 1575000000.00
OXY.TO balance_sheet (quarterly, 2025-12-31) — Current Debt: 1575000000.00
OXY.TO balance_sheet (annual, 2025-12-31) — Current Debt And Capital Lease Obligation: 2123000000.00
OXY.TO balance_sheet (quarterly, 2025-12-31) — Current Debt And Capital Lease Obligation: 2123000000.00
OXY.TO balance_sheet (annual, 2025-12-31) — Current Liabilities: 9428000000.00
OXY.TO balance_sheet (quarterly, 2025-12-31) — Current Liabilities: 9428000000.00
OXY.TO balance_sheet (annual, 2025-12-31) — Current Provisions: 381000000.00
OXY.TO balance_sheet (quarterly, 2025-12-31) — Current Provisions: 381000000.00
OXY.TO cash_flow (annual, 2025-12-31) — Deferred Income Tax: 127000000.00
OXY.TO cash_flow (quarterly, 2025-12-31) — Deferred Income Tax: 126000000.00
OXY.TO cash_flow (annual, 2025-12-31) — Deferred Tax: 127000000.00
OXY.TO cash_flow (quarterly, 2025-12-31) — Deferred Tax: 126000000.00
OXY.TO cash_flow (annual, 2025-12-31) — Depreciation Amortization Depletion: 7533000000.00
OXY.TO cash_flow (quarterly, 2025-12-31) — Depreciation Amortization Depletion: 1619000000.00
OXY.TO income_statement (annual, 2025-12-31) — Diluted Average Shares: 3308769938.00
OXY.TO income_statement (quarterly, 2025-12-31) — Diluted Average Shares: 3318033567.00
OXY.TO income_statement (annual, 2025-12-31) — Diluted EPS: 0.49
OXY.TO income_statement (quarterly, 2025-12-31) — Diluted EPS: -0.02
OXY.TO income_statement (annual, 2025-12-31) — Diluted NI Availto Com Stockholders: 1612000000.00
OXY.TO income_statement (quarterly, 2025-12-31) — Diluted NI Availto Com Stockholders: -68000000.00
OXY.TO balance_sheet (annual, 2025-12-31) — Dividends Payable: 383000000.00
OXY.TO balance_sheet (quarterly, 2025-12-31) — Dividends Payable: 383000000.00
OXY.TO balance_sheet (annual, 2025-12-31) — Duefrom Related Parties Current: 684000000.00
OXY.TO balance_sheet (quarterly, 2025-12-31) — Duefrom Related Parties Current: 684000000.00
OXY.TO income_statement (annual, 2025-12-31) — EBIT: 4131000000.00
OXY.TO income_statement (quarterly, 2025-12-31) — EBIT: 31000000.00
OXY.TO income_statement (annual, 2025-12-31) — EBITDA: 11664000000.00
OXY.TO income_statement (quarterly, 2025-12-31) — EBITDA: 1650000000.00
OXY.TO income_statement (annual, 2025-12-31) — Earnings From Equity Interest Net Of Tax: 76000000.00
OXY.TO cash_flow (annual, 2025-12-31) — Earnings Losses From Equity Investments: 619000000.00
OXY.TO balance_sheet (annual, 2025-12-31) — Employee Benefits: 985000000.00
OXY.TO balance_sheet (quarterly, 2025-12-31) — Employee Benefits: 985000000.00
OXY.TO cash_flow (annual, 2025-12-31) — End Cash Position: 2046000000.00
OXY.TO cash_flow (quarterly, 2025-12-31) — End Cash Position: 2046000000.00
OXY.TO cash_flow (annual, 2025-12-31) — Financing Cash Flow: -4844000000.00
OXY.TO cash_flow (quarterly, 2025-12-31) — Financing Cash Flow: -974000000.00
OXY.TO balance_sheet (annual, 2025-12-31) — Finished Goods: 601000000.00
OXY.TO balance_sheet (quarterly, 2025-12-31) — Finished Goods: 601000000.00
OXY.TO cash_flow (annual, 2025-12-31) — Free Cash Flow: 4105000000.00
OXY.TO cash_flow (quarterly, 2025-12-31) — Free Cash Flow: 1881000000.00
OXY.TO income_statement (annual, 2025-12-31) — Gain On Sale Of Ppe: 263000000.00
OXY.TO income_statement (quarterly, 2025-12-31) — Gain On Sale Of Ppe: 250000000.00
OXY.TO balance_sheet (annual, 2025-12-31) — Gains Losses Not Affecting Retained Earnings: 202000000.00
OXY.TO balance_sheet (quarterly, 2025-12-31) — Gains Losses Not Affecting Retained Earnings: 202000000.00
OXY.TO balance_sheet (annual, 2025-12-31) — Gross PPE: 138661000000.00
OXY.TO balance_sheet (quarterly, 2025-12-31) — Gross PPE: 138661000000.00
OXY.TO income_statement (annual, 2025-12-31) — Gross Profit: 7543000000.00
OXY.TO income_statement (quarterly, 2025-12-31) — Gross Profit: 840000000.00
OXY.TO balance_sheet (annual, 2025-12-31) — Income Tax Payable: 159000000.00
OXY.TO balance_sheet (quarterly, 2025-12-31) — Income Tax Payable: 159000000.00